Meadow Creek Investment Management LLC raised its holdings in shares of Steris PLC (NYSE:STE) by 19.4% in the 4th quarter, Holdings Channel reports. The firm owned 5,520 shares of the medical equipment provider’s stock after buying an additional 896 shares during the quarter. Meadow Creek Investment Management LLC’s holdings in Steris were worth $483,000 at the end of the most recent reporting period.
Several other institutional investors and hedge funds have also recently made changes to their positions in the company. BlackRock Inc. raised its stake in shares of Steris by 3.4% in the fourth quarter. BlackRock Inc. now owns 7,184,409 shares of the medical equipment provider’s stock valued at $628,419,000 after acquiring an additional 239,200 shares during the period. ArrowMark Colorado Holdings LLC raised its stake in shares of Steris by 0.8% in the fourth quarter. ArrowMark Colorado Holdings LLC now owns 1,487,376 shares of the medical equipment provider’s stock valued at $130,101,000 after acquiring an additional 11,742 shares during the period. American Century Companies Inc. raised its stake in shares of Steris by 14.6% in the fourth quarter. American Century Companies Inc. now owns 1,194,167 shares of the medical equipment provider’s stock valued at $104,454,000 after acquiring an additional 152,346 shares during the period. Wells Fargo & Company MN raised its stake in shares of Steris by 6.6% in the fourth quarter. Wells Fargo & Company MN now owns 1,105,452 shares of the medical equipment provider’s stock valued at $96,694,000 after acquiring an additional 68,881 shares during the period. Finally, Bank of New York Mellon Corp raised its stake in shares of Steris by 4.9% in the third quarter. Bank of New York Mellon Corp now owns 1,017,810 shares of the medical equipment provider’s stock valued at $89,974,000 after acquiring an additional 47,682 shares during the period. 89.40% of the stock is currently owned by institutional investors and hedge funds.
Several brokerages have recently weighed in on STE. Zacks Investment Research raised shares of Steris from a “hold” rating to a “buy” rating and set a $107.00 target price on the stock in a research note on Monday, March 19th. KeyCorp reissued a “buy” rating and issued a $103.00 target price on shares of Steris in a research note on Thursday, February 8th. Northcoast Research set a $102.00 target price on shares of Steris and gave the company a “buy” rating in a research note on Thursday, February 8th. Finally, Raymond James Financial reissued a “market perform” rating and issued a $100.00 target price on shares of Steris in a research note on Wednesday, January 3rd. Three research analysts have rated the stock with a hold rating and four have issued a buy rating to the stock. The stock has an average rating of “Buy” and an average price target of $85.60.
Shares of Steris PLC (NYSE:STE) opened at $89.69 on Monday. The firm has a market cap of $7,610.02, a price-to-earnings ratio of 31.47 and a beta of 1.17. Steris PLC has a 12 month low of $67.55 and a 12 month high of $96.43. The company has a quick ratio of 2.22, a current ratio of 2.82 and a debt-to-equity ratio of 0.46.
Steris (NYSE:STE) last posted its quarterly earnings results on Wednesday, February 7th. The medical equipment provider reported $1.12 EPS for the quarter, topping the Thomson Reuters’ consensus estimate of $1.07 by $0.05. The company had revenue of $661.90 million for the quarter, compared to the consensus estimate of $663.17 million. Steris had a net margin of 9.42% and a return on equity of 11.57%. The firm’s revenue was up 2.3% compared to the same quarter last year. During the same quarter last year, the firm posted $0.98 EPS. sell-side analysts expect that Steris PLC will post 4.13 EPS for the current year.
The business also recently declared a quarterly dividend, which will be paid on Wednesday, March 28th. Investors of record on Wednesday, February 28th will be paid a $0.31 dividend. This represents a $1.24 annualized dividend and a yield of 1.38%. The ex-dividend date is Tuesday, February 27th. This is an increase from Steris’s previous quarterly dividend of $0.21. Steris’s dividend payout ratio (DPR) is currently 43.51%.
ILLEGAL ACTIVITY WARNING: “Meadow Creek Investment Management LLC Grows Holdings in Steris PLC (STE)” was first published by Ticker Report and is the sole property of of Ticker Report. If you are viewing this report on another site, it was stolen and reposted in violation of United States and international trademark and copyright law. The legal version of this report can be viewed at https://www.tickerreport.com/banking-finance/3301800/meadow-creek-investment-management-llc-grows-holdings-in-steris-plc-ste.html.
STERIS plc provides infection prevention and other procedural products and services. The Company operates through four segments: Healthcare Products, which offers infection prevention and procedural solutions for healthcare providers, including capital equipment and related maintenance, and installation services, as well as consumables; Healthcare Specialty Services, which provides a range of specialty services for healthcare providers, including hospital sterilization services, instrument and scope repairs, and linen management; Life Sciences, which offers capital equipment and consumable products, and equipment maintenance and specialty services for pharmaceutical manufacturers and research facilities, and Applied Sterilization Technologies, which offers contract sterilization and laboratory services for medical device and pharmaceutical customers and others.
Want to see what other hedge funds are holding STE? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Steris PLC (NYSE:STE).
Receive News & Ratings for Steris Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Steris and related companies with MarketBeat.com's FREE daily email newsletter.